ACET - CIK 0001720580
Adicet Bio, Inc. (ACET) reported net income of -$116.80M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$116.80M | +0.3% |
| FY 2024 | -$117.12M | +17.9% |
| FY 2023 | -$142.66M | -104.4% |
| FY 2022 | -$69.79M | -12.6% |
| FY 2021 | -$62.00M | -69.0% |
| FY 2020 | -$36.68M | -30.4% |
| FY 2019 | -$28.14M | -202.6% |
| FY 2018 | -$9.30M | +72.5% |
| FY 2017 |
Adicet Bio, Inc. (ACET) reported net income of -$116.80M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2017 and fiscal 2025, Adicet Bio, Inc.'s net income declined from -$33.78M to -$116.80M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$33.78M |
| - |